Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Vietnam
Open Access
- 1 December 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (12), 3739-3743
- https://doi.org/10.1128/aac.46.12.3739-3743.2002
Abstract
Among 730 Escherichia coli , 438 Klebsiella pneumoniae , and 141 Proteus mirabilis isolates obtained between September 2000 and September 2001 in seven hospitals in Ho Chi Minh City, Vietnam, 26.6% were resistant to ceftazidime, 30% were resistant to cefotaxime, 31.5% were resistant to ceftriaxone, 15.9% were resistant to cefoperazone, and 6% were resistant to cefepime. Resistance to imipenem was found in 5.6% of the isolates. In 55 strains producing extended-spectrum β-lactamases (32 E. coli isolates, 13 K. pneumoniae isolates, and 10 P. mirabilis isolates), structural genes for VEB-1 (25.5%), CTX-M (25.5%), SHV (38.1%), and TEM (76.3%) enzymes were detected alone or in combination. Sequencing of the PCR products obtained from the K. pneumoniae isolates revealed the presence of bla VEB-1 , bla CTX-M-14 , bla CTX-M-17 , bla SHV-2 , and bla TEM-1 . Molecular typing of the strains with a similar resistance phenotype to broad-spectrum cephalosporins indicated polyclonal spread. IS Ecp1 was presumably responsible for dissemination of the bla CTX-M-like gene.Keywords
This publication has 35 references indexed in Scilit:
- Prevalence of SHV-12 among Clinical Isolates of Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases and Identification of a Novel AmpC Enzyme (CMY-8) in Southern TaiwanAntimicrobial Agents and Chemotherapy, 2000
- CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymesInternational Journal of Antimicrobial Agents, 2000
- Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum β-Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2000
- A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates ofKlebsiella pneumoniaeandEscherichia coliin JapanFEMS Microbiology Letters, 2000
- Summation: β-lactam resistance surveillance in the Asia–Western Pacific RegionDiagnostic Microbiology and Infectious Disease, 1999
- Phenotypic and genotypic characterizations of chinese strains of Escherichia coli producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 1999
- Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 inPseudomonas aeruginosaFEMS Microbiology Letters, 1999
- The Evolution of Resistance to CephalosporinsClinical Infectious Diseases, 1997
- Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E testEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Synergy between clavulanic acid and newer β-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmnella typhimurium resistant to third-generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1988